LabTube.tv
  • settings
  • CC
  • 360p
  • 480p
  • 720p
  • 1080p
557 VIEWS | 0 LIKES

The Complete Guide to CAR Design & Construction

from Biotech Videos

CAR-T refers to Chimeric Antigen Receptor T-Cell Immunotherapy, which is a modification of the conventional T cell receptor TCR via a chimeric antigen receptor and is generally engineered into a monoclonal antibody antigen-binding domain. In the scFV segment, the modified CAR-T cells can specifically recognize tumor-associated antigens, and are not limited by MHC, so that the targeting, killing activity, and persistence of effector T cells are improved compared with conventional immune cells. CAR-T technology generally selects cytotoxic T lymphocytes (CTLs) for modification because CTLs recognize tumor antigens and release granzymes and perforin to kill tumors.

about 1 year ago

Recommended Videos

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy